Pick Up Pfizer For Under $30


I think its short term oversold conditions are going to get even more oversold. The S&P500 needs to burn off elevated sentiment so Pfizer (NYSE:PFE) could get caught in the downswing. Long term fundamentals are still strong with this stock though despite poor prevnar sales in Q2. Anything under $30 a share would be a good long term buy and hold entry point.

This entry was posted in Stock Picks and tagged . Bookmark the permalink.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.